Intelligent Bio Solutions Inc.
INBS | NASDAQ
$1.78
+$0.02 (+1.14%)
Nov 2, 2026, 10:58 AM ET · Market open
Fiscal Year Period Ending | FY 2026 Jun 30, 2026 | FY 2025 Jun 30, 2025 | FY 2024 Jun 30, 2024 | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|
PE Ratio | -0.27 | -0.86 | -0.29 | -3.15 | -14.03 | -58.32 |
PEG Ratio | 0 | 0.01 | 0.01 | 0.48 | 0.47 | -0.71 |
PS Ratio | 0.80 | 2.97 | 1.88 | 53.34 | n/a | 248.73 |
PB Ratio | 0.61 | 3.03 | 0.70 | 17.65 | 17.59 | 32.71 |
P/FCF Ratio | -0.28 | -0.92 | -0.60 | -8.51 | -31.18 | -43.61 |
P/OCF Ratio | -0.28 | -0.94 | -0.61 | -9.09 | -34.71 | -43.61 |
OCF/S Ratio | -282.96 | -317.03 | -307.59 | -586.96 | n/a | -570.39 |
Debt / Equity Ratio | 0.33 | 0.09 | 0.14 | 0.50 | n/a | n/a |
Quick Ratio | 1.35 | 0.65 | 1.42 | 0.49 | 2.33 | 4.94 |
Current Ratio | 1.44 | 0.77 | 1.57 | 0.66 | 2.33 | 4.94 |
Asset Turnover | 0.35 | 0.37 | 0.23 | 0.12 | n/a | 0.09 |
Interest Coverage | -1.17K | -174.82 | -61.52 | -56.35 | -1.11K | -5.09 |
Return on Equity | -225.57% | -352.75% | -121.94% | -279.86% | -125.38% | -46.73% |
Return on Assets | -104.10% | -128.11% | -73.71% | -102.68% | -67.24% | -32.19% |
Return on Invested Capital | -176.09% | -334.68% | -109.48% | -238.95% | -108.42% | -30.66% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 48.63% | 40.85% | 45.81% | 25.99% | n/a | 100% |
Net Profit Margin | -294.91% | -346.23% | -326.40% | -845.89% | n/a | -355.33% |
Pretax Profit Margin | -295.80% | -347.41% | -327.50% | -848.50% | n/a | -356.49% |
Operating Profit Margin | -299.11% | -348.71% | -330.46% | -1K% | n/a | -281.42% |
FCF Margin | -285.94% | -324.62% | -314.71% | -627.15% | n/a | -570.39% |
EBITDA Margin | -267.94% | -309.72% | -290.81% | -753.80% | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove INBS